Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Dark Comedy
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Music
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Thriller
Truck Series (TRUCK)
True Crime
Ultimate Fighting Championship (UFC)
US
Valorant
Western
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessRaymond James Upgrades HealthEquity to Strong Buy Despite Fraud Concerns

Raymond James Upgrades HealthEquity to Strong Buy Despite Fraud Concerns

Add to Favorite
Added to Favorite


Raymond James upgraded HealthEquity (NASDAQ:HQY) from Outperform to Strong Buy, setting a new price target of $115, slightly below the previous $120, citing confidence in the company’s ability to resolve near-term challenges despite ongoing industry-wide fraud risks.
The analysts acknowledged that increased fraud-related costs have led to reduced estimates, but emphasized that the issue is affecting financial institutions across the board, not just HealthEquity. Recent data shows a notable rise in attempted fraud incidents across banks and fintech firms, with over 35% reporting more than 1,000 attempts and two-thirds experiencing year-over-year increases.
Despite these pressures, Raymond James maintains a bullish outlook, expecting HealthEquity’s management to effectively mitigate current fraud issues in the near term. The firm also highlighted disclosures from the company’s recent 10-K filing, which confirmed that no known cybersecurity threats have had a material impact on operations or are expected to in the foreseeable future.
Raymond James sees the underlying fundamentals and strategic positioning of HealthEquity as strong, and believes the stock’s current levels offer an attractive opportunity for long-term investors, even amid short-term headwinds.

Subscribe to get Latest News Updates

Latest News

You may like more
more

VolitionRx Limited’s Upcoming Earnings Report: A Deep Dive into Financial Health and Future Prospects

VolitionRx Limited (NYSEAMERICAN:VNRX) is set to release its quarterly...

Recent Market Movements: Analysis of Top Losers

Milestone Pharmaceuticals Inc. (NASDAQ:MIST) saw a dramatic decrease of...

Ovintiv Inc. (NYSE: OVV) Set to Announce First Quarter 2025 Results

Ovintiv Inc. (NYSE:OVV) receives an upgrade from BMO Capital...

CACI International Inc. (NYSE:CACI) – A Promising Investment with Strong Growth Potential

CACI International Inc. (NYSE:CACI) has shown a strong performance...